PEI-PAAIO Hybrid Nanoparticles for Gene Transfection

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current magnetic transfection technologies using magnetic nanoparticles (MNPs) face challenges such as complex processing steps, low transfection efficiency, and stability issues, particularly in physiological conditions, which affect their safety and efficacy as drug delivery systems.

Innovation Solution

The development of superparamagnetic nanoparticles formed by reacting polyethylenimine (PEI) with polyacrylic acid-bound iron oxide (PAAIO) to create a polyelectrolyte complex, which is highly water-soluble, stable, and has low cytotoxicity, allowing for efficient encapsulation of genetic materials and improved transfection efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If magnetic nanoparticles are used for gene transfection, then transfection efficiency is improved, but processing steps become too complicated and stability is reduced

Engineering Contradiction:

Improvetransfection efficiencyVSAvoidprocessing steps

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent combines magnetic nanoparticles with polyethylenimine (PEI) and polyacrylic acid (PAA) to form a hybrid magnetoplex structure that integrates gene complexation and magnetic targeting functions in a single system, eliminating the need for separate coating and complexation steps required in conventional liposome-based methods

Inventive Principle:

Principle #5Merging (Combining)

Solution Approach 2:

The invention uses composite materials consisting of magnetic nanoparticles coated with PAA and complexed with PEI to create a stable hybrid structure that maintains both magnetic properties and gene delivery capability without requiring complex processing

Inventive Principle:

Principle #40Composite materials

2Productivity

If magnetic nanoparticles are used for gene transfection, then transfection efficiency is improved, but stability in physiological conditions deteriorates

Engineering Contradiction:

Improvetransfection efficiencyVSAvoidstability in physiological conditions

Core Design Contradiction:

ProductivityVSStability of the object's composition

Solution Approach 1:

The hybrid magnetoplex structure combining magnetic nanoparticles, PAA, and PEI creates a stable composite material that resists serum disruption and maintains structural integrity in physiological conditions, solving the stability problem of conventional MNPs

Inventive Principle:

Principle #40Composite materials

Solution Approach 2:

The patent modifies the surface properties and chemical composition of magnetic nanoparticles by coating with PAA and complexing with PEI, changing parameters such as surface charge, hydrophilicity, and structural stability to enhance resistance to physiological degradation

Inventive Principle:

Principle #35Parameter changes

3Productivity

If magnetic nanoparticles are used for gene transfection, then gene delivery is achieved, but cytotoxicity increases

Engineering Contradiction:

Improvegene delivery efficiencyVSAvoidcytotoxicity

Core Design Contradiction:

ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent reduces cytotoxicity by optimizing the molecular weight and concentration of PEI, and by modifying the surface properties of magnetic nanoparticles through PAA coating, creating a biocompatible hybrid structure that maintains gene delivery efficiency while minimizing cellular damage

Inventive Principle:

Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting nanoparticles demonstrate enhanced transfection efficiency, stability, and safety, with improved resistance to serum disruption, making them suitable for clinical applications like gene therapy.

Implementation Method 1

reacting a PEI with a polyacrylic acid-bound iron oxide (PAAIO) to obtain a polyelectrolyte complex (PEC)

Methodology Applied

Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 2

The MNPs can replace polyethylenimine (PEI) to be the non-viral gene vector... properties of superparamagnetism

Methodology Applied

Scientific EffectSuperparamagnetism: Superparamagnetism

Data Source

PatentUS9050362B2Hybrid superparamagnetic iron oxide nanoparticles and polyethylenimine as a magnetocomplex for gene transfection

Publication Date: 2015.06.09 KAOHSIUNG MEDICAL UNIVERSITY

AI summary

Disclosed are the nanoparticle and the method for the same, and the preparing method includes steps of mixing polyethylenimine (PEI) with the poly(acrylic acid)-bound iron oxide (PAAIO) to form a PEI-PAAIO polyelectrolyte complex (PEC) and mixing the PEI-PAAIO PEC with genetic material such as plasmid DNA to form the PEI-PAAIO/pDNA magnetic nanoparticle. The PEI-PAAIO/pDNA magnetoplex is highly water dispersible and suitable for long term storage, shows superparamagnetism, low cytotoxicity, high stability and nice transfection efficiency, and thus the PEI-PAAIO PEC can replace PEI as a non-viral gene vector.